31138794|t|SORLA regulates endosomal trafficking and oncogenic fitness of HER2.
31138794|a|The human epidermal growth factor receptor 2 (HER2) is an oncogene targeted by several kinase inhibitors and therapeutic antibodies. While the endosomal trafficking of many other receptor tyrosine kinases is known to regulate their oncogenic signalling, the prevailing view on HER2 is that this receptor is predominantly retained on the cell surface. Here, we find that sortilin-related receptor 1 (SORLA; SORL1) co-precipitates with HER2 in cancer cells and regulates HER2 subcellular distribution by promoting recycling of the endosomal receptor back to the plasma membrane. SORLA protein levels in cancer cell lines and bladder cancers correlates with HER2 levels. Depletion of SORLA triggers HER2 targeting to late endosomal/lysosomal compartments and impairs HER2-driven signalling and in vivo tumour growth. SORLA silencing also disrupts normal lysosome function and sensitizes anti-HER2 therapy sensitive and resistant cancer cells to lysosome-targeting cationic amphiphilic drugs. These findings reveal potentially important SORLA-dependent endosomal trafficking-linked vulnerabilities in HER2-driven cancers.
31138794	0	5	SORLA	Gene	6653
31138794	63	67	HER2	Gene	2064
31138794	73	78	human	Species	9606
31138794	79	113	epidermal growth factor receptor 2	Gene	2064
31138794	115	119	HER2	Gene	2064
31138794	346	350	HER2	Gene	2064
31138794	439	466	sortilin-related receptor 1	Gene	6653
31138794	468	473	SORLA	Gene	6653
31138794	475	480	SORL1	Gene	6653
31138794	503	507	HER2	Gene	2064
31138794	511	517	cancer	Disease	MESH:D009369
31138794	538	542	HER2	Gene	2064
31138794	646	651	SORLA	Gene	6653
31138794	670	676	cancer	Disease	MESH:D009369
31138794	692	707	bladder cancers	Disease	MESH:D001749
31138794	724	728	HER2	Gene	2064
31138794	750	755	SORLA	Gene	6653
31138794	765	769	HER2	Gene	2064
31138794	833	837	HER2	Gene	2064
31138794	868	874	tumour	Disease	MESH:D009369
31138794	883	888	SORLA	Gene	6653
31138794	958	962	HER2	Gene	2064
31138794	995	1001	cancer	Disease	MESH:D009369
31138794	1030	1056	cationic amphiphilic drugs	Chemical	-
31138794	1102	1107	SORLA	Gene	6653
31138794	1166	1170	HER2	Gene	2064
31138794	1178	1185	cancers	Disease	MESH:D009369
31138794	Association	2064	6653
31138794	Association	MESH:D001749	2064
31138794	Association	MESH:D009369	2064
31138794	Association	MESH:D009369	6653
31138794	Association	MESH:D001749	6653

